Information about Ring Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0472.540.052

VAT liability
Yes
Established
03-08-2000
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Market research and public opinion polling
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Ring Pharma

2024 2023 2022 2021
Profit/Loss 5,037 105 % -100,228 -86 % -53,935 -211 % -17,361
Equity 102,532 5 % 97,495 -51 % 197,724 -21 % 251,659
Gross margin 37,930 42 % 26,684 -58 % 62,887 -37 % 100,165

Publications from Ring Pharma

Date Publication
31-08-2022 Resignations - Appointments - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
17-11-2017 Resignations - Appointments (NL)
04-05-2015 Registered Office - Resignations - Appointments (NL)
29-07-2011 Resignations - Appointments (NL)
15-01-2009 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Ring Pharma?
The VAT number of Ring Pharma is BE 0472.540.052.
Wat is the PEPPOL ID of Ring Pharma?
The PEPPOL ID of Ring Pharma is 0208:0472540052. Log in or start a free trial to see the full overview.
When was Ring Pharma founded?
Ring Pharma was founded on 03-08-2000.
What is the address of Ring Pharma?
The current registered office of Ring Pharma is located at Kerkeblokstraat 5-7, 1850 Grimbergen.
When was the last time Ring Pharma filed their annual financial statements?
The most recent financial statements of Ring Pharma were filed on 25-04-2025.
How many employees does Ring Pharma have?
There are currently no employees working at Ring Pharma or no workforce information is available.
What is the annual turnover of Ring Pharma?
At the time of its most recent financial statements, Ring Pharma did not publish any turnover figures. Ring Pharma reported a gross margin of €37,930.37.